Australia markets closed

BridgeBio Pharma, Inc. (BBIO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
27.83+0.09 (+0.32%)
At close: 04:00PM EDT
27.83 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts8101011
Avg. Estimate-0.89-0.93-2.89-3.12
Low estimate-1.08-1.1-4.26-5.14
High estimate-0.74-0.77-0.79-1.84
Year ago EPS-0.92-0.98-3.95-2.89
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts4679
Avg. EstimateN/A3.86M186.97M175.2M
Low estimateN/AN/A12.9M116.1M
High estimate52M15M459.78M230.88M
Year ago sales1.83MN/A9.3M186.97M
Sales growth (year/est)N/AN/A1,909.80%-6.30%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.83-0.83-0.82-0.91
Actual EPS-0.92-0.98-1.08-0.96
Difference-0.09-0.15-0.26-0.05
Surprise %-10.80%-18.10%-31.70%-5.50%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.89-0.93-2.89-3.12
7 days ago-0.89-0.9-3.27-3.06
30 days ago-0.92-0.94-3.25-3.03
60 days ago-0.91-1-3.62-3.26
90 days ago-0.93-0.94-3.44-3.12
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/A3N/A
Up last 30 daysN/AN/A3N/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/A2N/A2
Growth estimatesBBIOIndustrySector(s)S&P 500
Current qtr.3.30%N/AN/AN/A
Next qtr.5.10%N/AN/AN/A
Current year26.80%N/AN/AN/A
Next year-8.00%N/AN/AN/A
Next 5 years (per annum)67.30%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A